Terms: = Kidney tumors AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS
167 results:
1. Targeting apoptosis and unfolded protein response: the impact of β-hydroxybutyrate in clear cell renal cell carcinoma under glucose-deprived conditions.
Roohy F; Siri M; Kohansal K; Ghalandari A; Rezaei R; Maleki MH; Shams M; Monsef A; Dastghaib S
Mol Biol Rep; 2024 Jan; 51(1):168. PubMed ID: 38252187
[TBL] [Abstract] [Full Text] [Related]
2. Afatinib-Induced Tumor Lysis Syndrome in Pulmonary Adenocarcinoma: A Case Report and Literature Review.
Hong G
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138247
[TBL] [Abstract] [Full Text] [Related]
3. Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment
Xu W; Lu J; Liu WR; Anwaier A; Wu Y; Tian X; Su JQ; Qu YY; Yang J; Zhang H; Ye D
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040418
[TBL] [Abstract] [Full Text] [Related]
4. Collision kidney Tumor Consisting of Clear Cell Renal Cell Carcinoma and Primary Renal Mantle Cell Lymphoma: A Case Report.
Yang H; Wang P
Arch Esp Urol; 2023 Oct; 76(8):627-632. PubMed ID: 37960962
[TBL] [Abstract] [Full Text] [Related]
5. Knockdown of NR3C1 inhibits the proliferation and migration of clear cell renal cell carcinoma through activating endoplasmic reticulum stress-mitophagy.
Yan M; Wang J; Wang H; Zhou J; Qi H; Naji Y; Zhao L; Tang Y; Dai Y
J Transl Med; 2023 Oct; 21(1):701. PubMed ID: 37807060
[TBL] [Abstract] [Full Text] [Related]
6. Expression of GRP78 and its copartners in HEK293 and pancreatic cancer cell lines (BxPC-3/PANC-1) exposed to MRI and CT contrast agents.
Azzawri AA; Yildirim IH; Yegin Z; Dusak A
Nucleosides Nucleotides Nucleic Acids; 2024; 43(5):391-416. PubMed ID: 37787049
[TBL] [Abstract] [Full Text] [Related]
7. Extracellular vesicle-circEHD2 promotes the progression of renal cell carcinoma by activating cancer-associated fibroblasts.
He T; Zhang Q; Xu P; Tao W; Lin F; Liu R; Li M; Duan X; Cai C; Gu D; Zeng G; Liu Y
Mol Cancer; 2023 Jul; 22(1):117. PubMed ID: 37481520
[TBL] [Abstract] [Full Text] [Related]
8. Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma.
Zhang D; Ni Y; Wang Y; Feng J; Zhuang N; Li J; Liu L; Shen W; Zheng J; Zheng W; Qian C; Shan J; Zhou Z
J Transl Med; 2023 Jul; 21(1):489. PubMed ID: 37474942
[TBL] [Abstract] [Full Text] [Related]
9. [Cordycepin, a metabolite of
Zheng Q; Shao Y; Zheng W; Zou Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):873-878. PubMed ID: 37439158
[TBL] [Abstract] [Full Text] [Related]
10. Prediction values of tertiary lymphoid structures in the prognosis of patients with left- and right-sided colon cancer: a multicenter propensity score-matched study.
Mao Y; Wang X; Xi L; Dong M; Song P; Miao J; Lu C; Sun S; Li Q; Yu C; Shen X
Int J Surg; 2023 Aug; 109(8):2344-2358. PubMed ID: 37247038
[TBL] [Abstract] [Full Text] [Related]
11. Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Ng KW; Boumelha J; Enfield KSS; Almagro J; Cha H; Pich O; Karasaki T; Moore DA; Salgado R; Sivakumar M; Young G; Molina-Arcas M; de Carné Trécesson S; Anastasiou P; Fendler A; Au L; Shepherd STC; Martínez-Ruiz C; Puttick C; Black JRM; Watkins TBK; Kim H; Shim S; Faulkner N; Attig J; Veeriah S; Magno N; Ward S; Frankell AM; Al Bakir M; Lim EL; Hill MS; Wilson GA; Cook DE; Birkbak NJ; Behrens A; Yousaf N; Popat S; Hackshaw A; ; ; Hiley CT; Litchfield K; McGranahan N; Jamal-Hanjani M; Larkin J; Lee SH; Turajlic S; Swanton C; Downward J; Kassiotis G
Nature; 2023 Apr; 616(7957):563-573. PubMed ID: 37046094
[TBL] [Abstract] [Full Text] [Related]
12. The roles of tertiary lymphoid structures in chronic diseases.
Sato Y; Silina K; van den Broek M; Hirahara K; Yanagita M
Nat Rev Nephrol; 2023 Aug; 19(8):525-537. PubMed ID: 37046081
[TBL] [Abstract] [Full Text] [Related]
13. Tumour lysis syndrome as a rare complication of chemotherapy in paediatric Wilms' Tumour: a case report.
Qamar S; Sindhu II; Shaheen N
J Pak Med Assoc; 2023 Mar; 73(3):700-704. PubMed ID: 36932788
[TBL] [Abstract] [Full Text] [Related]
14. The clinicopathological spectrum of sclerosing epithelioid fibrosarcoma: report of an additional series with review of the literature.
Peng Y; Zhang D; Lei T; Xie J; Wu C; Wang H; Shi Y; Li Q; Wang J
Pathology; 2023 Apr; 55(3):355-361. PubMed ID: 36690575
[TBL] [Abstract] [Full Text] [Related]
15. Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.
Vassilakopoulos TP; Panitsas F; Mellios Z; Apostolidis J; Michael M; Gurion R; Ferhanoglu B; Hatzimichael E; Karakatsanis S; Dimou M; Kalpadakis C; Katodritou E; Leonidopoulou T; Kotsianidis I; Giatra H; Kanellias N; Sayyed A; Tadmor T; Akay OM; Angelopoulou MK; Horowitz N; Bakiri M; Pangalis GA; Panayiotidis P; Papageorgiou SG
Hematol Oncol; 2023 Feb; 41(1):97-107. PubMed ID: 36314897
[TBL] [Abstract] [Full Text] [Related]
16. Sodium and Potassium Dysregulation in the Patient With Cancer.
Ratanasrimetha P; Workeneh BT; Seethapathy H
Adv Chronic Kidney Dis; 2022 Mar; 29(2):171-179.e1. PubMed ID: 35817524
[TBL] [Abstract] [Full Text] [Related]
17. Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR).
van der Mijn JC; Chen Q; Laursen KB; Khani F; Wang X; Dorsaint P; Sboner A; Gross SS; Nanus DM; Gudas LJ
Mol Carcinog; 2022 Sep; 61(9):851-864. PubMed ID: 35726553
[TBL] [Abstract] [Full Text] [Related]
18. Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study.
Carril-Ajuria L; Desnoyer A; Meylan M; Dalban C; Naigeon M; Cassard L; Vano Y; Rioux-Leclercq N; Chouaib S; Beuselinck B; Chabaud S; Barros-Monteiro J; Bougoüin A; Lacroix G; Colina-Moreno I; Tantot F; Boselli L; De Oliveira C; Fridman WH; Escudier B; Sautes-Fridman C; Albiges L; Chaput-Gras N
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35640928
[TBL] [Abstract] [Full Text] [Related]
19. CD20
Wu Z; Zhou J; Xiao Y; Ming J; Zhou J; Dong F; Zhou X; Xu Z; Zhao X; Lei P; Huang T
Front Immunol; 2022; 13():865596. PubMed ID: 35634306
[TBL] [Abstract] [Full Text] [Related]
20. The tricks for fighting against cancer using CAR NK cells: A review.
Vahidian F; Khosroshahi LM; Akbarzadeh M; Jahanban-Esfahlan A; Baghbanzadeh A; Ali-Hassanzadeh M; Safarzadeh E
Mol Cell Probes; 2022 Jun; 63():101817. PubMed ID: 35436564
[TBL] [Abstract] [Full Text] [Related]
[Next]
